Literature DB >> 15596145

Expression of interleukin-17B in mouse embryonic limb buds and regulation by BMP-7 and bFGF.

Zongbing You1, Grayson DuRaine, Janet Y L Tien, Corinne Lee, Timothy A Moseley, A Hari Reddi.   

Abstract

Interleukin-17B (IL-17B) is a member of interleukin-17 family that displays a variety of proinflammatory and immune modulatory activities. In this study, we found that IL-17B mRNA was maximally expressed in the limb buds of 14.5 days post coitus (dpc) mouse embryo and declined to low level at 19.5 dpc. By immunohistochemical staining, the strongest IL-17B signals were observed in the cells of the bone collar in the primary ossification center. The chondrocytes in the resting and proliferative zones were stained moderately, while little staining was seen in the hypertrophic zone. Furthermore, in both C3H10T1/2 and MC3T3-E1 cells, the IL-17B mRNA was up-regulated by recombinant human bone morphogenetic protein-7, but down-regulated by basic fibroblast growth factor via the extracellular signal-regulated kinase pathway. This study provides the first evidence that IL-17B is expressed in the mouse embryonic limb buds and may play a role in chondrogenesis and osteogenesis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15596145     DOI: 10.1016/j.bbrc.2004.11.087

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

Review 1.  IL-17 family member cytokines: regulation and function in innate immunity.

Authors:  Joseph M Reynolds; Pornpimon Angkasekwinai; Chen Dong
Journal:  Cytokine Growth Factor Rev       Date:  2010-11-11       Impact factor: 7.638

Review 2.  The IL-17 family cytokines in immunity and disease.

Authors:  Rajita Pappu; Vladimir Ramirez-Carrozzi; Naruhisa Ota; Wenjun Ouyang; Yan Hu
Journal:  J Clin Immunol       Date:  2010-02-23       Impact factor: 8.317

Review 3.  The interleukin-17 cytokine family: critical players in host defence and inflammatory diseases.

Authors:  Rajita Pappu; Vladimir Ramirez-Carrozzi; Arivazhagan Sambandam
Journal:  Immunology       Date:  2011-07-04       Impact factor: 7.397

Review 4.  Interleukin 17 Family Cytokines: Signaling Mechanisms, Biological Activities, and Therapeutic Implications.

Authors:  Leticia Monin; Sarah L Gaffen
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-04-02       Impact factor: 10.005

5.  Interleukin-17B Antagonizes Interleukin-25-Mediated Mucosal Inflammation.

Authors:  Joseph M Reynolds; Young-Hee Lee; Yun Shi; Xiaohu Wang; Pornpimon Angkasekwinai; Kalyan C Nallaparaju; Stephanie Flaherty; Seon Hee Chang; Hiroshi Watarai; Chen Dong
Journal:  Immunity       Date:  2015-04-14       Impact factor: 31.745

6.  Differential expression of IL-17RC isoforms in androgen-dependent and androgen-independent prostate cancers.

Authors:  Zongbing You; Ying Dong; Xiangtian Kong; Yi Zhang; Robert L Vessella; Jonathan Melamed
Journal:  Neoplasia       Date:  2007-06       Impact factor: 5.715

7.  IL-17B activated mesenchymal stem cells enhance proliferation and migration of gastric cancer cells.

Authors:  Qingli Bie; Bin Zhang; Caixia Sun; Xiaoyun Ji; Prince Amoah Barnie; Chen Qi; Jingjing Peng; Danyi Zhang; Dong Zheng; Zhaoliang Su; Shengjun Wang; Huaxi Xu
Journal:  Oncotarget       Date:  2017-03-21

8.  IL-17B/IL-17RB signaling cascade contributes to self-renewal and tumorigenesis of cancer stem cells by regulating Beclin-1 ubiquitination.

Authors:  Qingli Bie; Hui Song; Xinke Chen; Xiao Yang; Shuo Shi; Lihua Zhang; Rou Zhao; Li Wei; Baogui Zhang; Huabao Xiong; Bin Zhang
Journal:  Oncogene       Date:  2021-03-01       Impact factor: 9.867

9.  Midkine is a NF-kappaB-inducible gene that supports prostate cancer cell survival.

Authors:  Zongbing You; Ying Dong; Xiangtian Kong; Laurel A Beckett; Regina Gandour-Edwards; Jonathan Melamed
Journal:  BMC Med Genomics       Date:  2008-02-14       Impact factor: 3.063

10.  Expression of interleukin-17RC protein in normal human tissues.

Authors:  Dongxia Ge; Zongbing You
Journal:  Int Arch Med       Date:  2008-10-17
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.